Some trial participants skilled a slight rise in resting coronary heart price, which has also been noticed with other GLP-one receptor agonists. Nevertheless, its exclusive motion on glucagon receptors calls for even more exploration to evaluate extended-phrase metabolic outcomes.Generally c